A District Court in Washington, D.C. has dismissed a case brought by physician Haroon I. Hameed against the Drug Enforcement Administration (DEA). Hameed alleged that the DEA unreasonably delayed a decision on his registration renewal. The court ruled that the case was moot because the DEA had already issued a final decision on Hameed's application.
This ruling affects Hameed, who has faced challenges in maintaining his medical practice due to issues surrounding his DEA registration. The decision highlights the complexities of administrative procedures and the legal avenues available to those seeking to challenge agency actions.
Background
Haroon I. Hameed is a physician based in Washington, D.C., who practices medicine in Maryland. His troubles began in November 2020 when the Maryland State Board of Physicians suspended his medical license. This suspension was due to allegations of practicing medicine while under the influence of controlled substances and alcohol. After completing a rehabilitation program, the Board lifted the suspension.
In November 2021, Hameed applied to renew his DEA registration, which allows him to prescribe controlled substances. However, the DEA found that his application contained false statements regarding his medical license suspension and issued an order to show cause why his application should not be denied. Hameed waived his right to a hearing and submitted a written response in April 2022. Despite this, more than three years passed before Hameed filed his lawsuit in May 2025, claiming that the DEA had unreasonably delayed a decision.
The Ruling
Judge Dabney L. Friedrich presided over the case, identified as Civil Action No. 2025-1588. The court ruled that Hameed's claims were moot because the DEA had issued a final decision revoking his registration in September 2025. The court stated, "once the [agency] has rendered a final decision, the issue of regulatory delay will be moot and beyond [the court’s] effective power to remedy." This ruling effectively dismissed Hameed's claims regarding the delay and his due process rights.
Additionally, the court noted that Hameed's due process claims fell under an exclusive review scheme established by Congress. The court emphasized that Hameed could not bypass this scheme through his lawsuit in district court. The ruling pointed out that the D.C. Circuit had already reviewed and rejected Hameed's due process arguments, stating that he had not identified any specific harms caused by the delay.
Impact
The dismissal of Hameed's case sets a precedent regarding the limits of judicial review in administrative matters, particularly concerning the DEA's actions. It underscores the importance of following the correct legal procedures when challenging agency decisions. Hameed's situation illustrates the challenges faced by medical professionals when their licenses and registrations are under scrutiny.
This ruling may have broader implications for other medical practitioners facing similar situations. It emphasizes the need for timely action and adherence to established procedures when dealing with regulatory bodies like the DEA. The case also highlights the potential consequences of administrative delays and the legal recourse available to affected individuals.
What's Next
Hameed's case cannot be appealed in the district court, as the ruling is final. However, he has already sought review of the DEA's decision in the D.C. Circuit, which has denied his petition. There are no indications of related cases pending that would impact this ruling.